Apogee Therapeutics, Inc. (NASDAQ: APGE) on Tuesday shared interim data from the Phase 1b trial of zumilokibart (APG777) in patients with mild-to-moderate asthma. The data covers 19 adult patients ...

Move comes 2 years after controversial exit of brand-name product ...

Chinese scientists have developed a groundbreaking cell therapy that could provide long-term relief for asthma patients with just a single shot. This new treatment, which has shown promising results ...

Among patients with asthma without diabetes, the risk for exacerbation was decreased with GLP-1 receptor agonist exposure, ...

Quick-relief meds, also called rescue or short-acting drugs, are just what they sound like an 11th-hour Hail Mary when an asthma attack kicks in. “Whereas long-term and control medications treat ...

Tony Cook runs up to 7 miles a day, but until recently, his severe asthma made it too painful for him to work out for very long. “It feels like a coil is just tightening around your lungs and you ...

More than 24 million Americans have been diagnosed with asthma, and 10 percent of them have a tough time controlling it, even with treatment. But a new form of therapy -- known as biologic -- is ...

The price of asthma medication has soared in the U.S. over the past decade and a half. I’m a health law professor at Villanova University, where I study whether patients can get the medicines they ...

JACKSON , MS, UNITED STATES, March 10, 2026 /EINPresswire.com/ -- As the warmer weather of spring approaches, so does ...

Current asthma treatments don't work in all patients, and they don't provide long-term relief from potentially deadly asthma attacks. Scientists at La Jolla Institute for Immunology (LJI) are ...

This summer’s family barbecue was supposed to be a celebration of sorts—coming together for the first time since the pandemic pulled the plug on group activities. But your joy was cut short by an ...